XML 50 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of grants of share-based awards
The following grants of share-based awards were made in 2018 under the 2005 Incentive Plan: 
Date of Grant
 
 
Shares
 
 
Grant Date
Fair Value
Per Share/Unit
 
Vesting Period
 
 
 
 
 
 
 
 
 
 
 
January 2, 2018 (1)
 
 
449,271

 
 
 
$
7.54

 
 
33% per year over three years
January 2, 2018 (2)
 
 
449,271

 
 
 
$
10.44

 
 
100% on January 2, 2021
January 2, 2018 (3)
 
 
8,247

 
 
 
$
7.54

 
 
100% on January 1, 2020
April 2, 2018 (3)
 
 
11,064

 
 
 
$
5.79

 
 
100% on January 1, 2020
July 2, 2018 (3)
 
 
6,565

 
 
 
$
8.33

 
 
100% on January 1, 2020
August 21, 2018 (4)
 
 
6,093

 
 
 
$
8.97

 
 
100% on August 21, 2019
October 1, 2018 (3)
 
 
6,104

 
 
 
$
9.88

 
 
100% on January 1, 2020
December 13, 2018 (5)
 
 
126,942

 
 
 
$
7.09

 
 
100% on December 13, 2019
(1)
Reflects grants of restricted stock to our executive officers.
(2)
Reflects grants of PSUs to our executive officers. These awards when vested can only be settled in shares of our common stock.
(3)
Reflects grants of restricted stock to certain independent members of our Board who have made an election to take their quarterly fees in stock in lieu of cash.
(4)
Reflects a grant of restricted stock made to an independent member of our Board upon his joining our Board.
(5)
Reflects annual equity grants to each independent member of our Board.
Summary of information about restricted stock
The following table summarizes information about our restricted stock: 
 
Year Ended December 31,
 
2018
 
2017
 
2016
 
Shares
 
Grant Date
Fair Value (1)
 
Shares
 
Grant Date
Fair Value (1)
 
Shares
 
Grant Date
Fair Value (1)
 
 
 
 
 
 
 
 
 
 
 
 
Awards outstanding at beginning of year
1,579,218

 
$
7.63

 
1,577,973

 
$
7.86

 
661,124

 
$
16.28

Granted
614,286

 
7.46

 
829,143

 
8.39

 
1,298,121

 
5.70

Vested (2)
(823,310
)
 
7.88

 
(817,791
)
 
8.84

 
(305,588
)
 
16.94

Forfeited
(49,205
)
 
7.62

 
(10,107
)
 
7.01

 
(75,684
)
 
7.76

Awards outstanding at end of year
1,320,989

 
$
7.40

 
1,579,218

 
$
7.63

 
1,577,973

 
$
7.86

(1)
Represents the weighted average grant date fair value, which is based on the quoted closing market price of our common stock on the trading day prior to the date of grant.
(2)
Total fair value of restricted stock that vested during the years ended December 31, 2018, 2017 and 2016 was $6.4 million, $6.9 million and $2.2 million, respectively.